Drugs / LEO 80185
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02605057 | Nov 2015 → Jul 2016 | psoriasis | LEO Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LEO 80185 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02605057 ↗ |
| Route | Topical | “a single application of LEO 80185 gel and Dovobet® ointment will be applied to multiple test sites on the back” NCT02605057 ↗ |